:format(webp)/cdn.vox-cdn.com/uploads/chorus_image/image/37177928/807deff2-9dd9-3541-0539-f73df92508c3_RTFY_210_0509_207.0.0.JPG)
Good news for fans of great TV shows that nobody watches and disappointing vampire shows we keep watching because they're so close to being good: both Sundance Channel's Rectify and FX's The Strain have been renewed, for their second and third seasons respectively.
Rectify, which will end its second season on Thursday, is one of TV's best shows, a piercing look at how a family handles the release of one of their own from prison after nearly 20 years. It's also a show pretty much nobody is watching, making Sundance's renewal of the show heartening. If that sounds at all interesting, you can watch season one on Netflix right now. It's short, at only six episodes. Presumably, season two will be added before season three debuts sometime next year so you can get all caught up.
The Strain, meanwhile, has been a big ol' hit for FX, regularly drawing over 2 million viewers first-run, with those numbers cresting 10 million once all viewing platforms are figured in. (FX, like many cable channels, is less dependent on first-run viewership numbers than a broadcast network would be, but 2 million viewers still marks this as one of the channel's biggest hits in that metric.) Critics (like us) have grumbled about the show's lack of forward momentum, but viewers clearly don't mind, as the show has held on to a sizable portion of its audience. If you want to watch, it's available on FX's FX Now app, and will run through October. Season two will air next year.
